Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
JAMA
.
2021 Oct 19;326(15):1536.
doi: 10.1001/jama.2021.13873.
Authors
David R W Jayne
1
,
Peter A Merkel
2
,
Pirow Bekker
3
Affiliations
1
University of Cambridge, Cambridge, England.
2
University of Pennsylvania, Philadelphia.
3
ChemoCentryx Inc, San Carlos, California.
PMID:
34665208
DOI:
10.1001/jama.2021.13873
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
Glucocorticoids*
Humans
Remission Induction
Rituximab
Substances
Glucocorticoids
Rituximab